These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3665630)

  • 61. [Fundamental and clinical studies on aztreonam in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1985 Nov; 38(11):3273-84. PubMed ID: 4094059
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chloramphenicol toxicity.
    Holt D; Harvey D; Hurley R
    Adverse Drug React Toxicol Rev; 1993; 12(2):83-95. PubMed ID: 8357947
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Fundamental and clinical evaluation on ceftriaxone in the pediatric field].
    Toyonaga Y; Kurosu Y; Uekusa T; Nakamura H; Sugita M; Okabe T; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1984 Nov; 37(11):2060-82. PubMed ID: 6098702
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pharmacokinetic and clinical studies of SY5555 in the pediatric field. Pediatric Study Group of SY5555].
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Sato H; Niino K; Suzuki H; Toyonaga Y; Nakamura H
    Jpn J Antibiot; 1994 Apr; 47(4):383-408. PubMed ID: 8201768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
    Toyonaga Y; Koizumi M; Imai H; Sugita M; Takahashi T; Fukushima Y; Yamasaki M; Hori M
    Jpn J Antibiot; 1989 Jul; 42(7):1519-46. PubMed ID: 2810728
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chloramphenicol pharmacokinetics in infants and young children.
    Sack CM; Koup JR; Smith AL
    Pediatrics; 1980 Oct; 66(4):579-84. PubMed ID: 7432844
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pharmacokinetic and clinical studies of cefpirome in pediatric field].
    Haruta T; Kuroki S; Okura K; Yamakawa M; Nigami H; Naramura M; Yoshida N; Kobayashi Y
    Jpn J Antibiot; 1991 Feb; 44(2):223-33. PubMed ID: 1828275
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetic comparison of intravenous and oral chloramphenicol in patients with Haemophilus influenzae meningitis.
    Yogev R; Kolling WM; Williams T
    Pediatrics; 1981 May; 67(5):656-60. PubMed ID: 6973130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Evaluation of cefuzonam in the pediatric field].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H; Nakazawa S; Chikaoka H; Koido R; Kamigaki M; Nakada Y
    Jpn J Antibiot; 1987 Mar; 40(3):613-29. PubMed ID: 3613082
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Flomoxef in neonates and young infants; clinical efficacy, pharmacokinetic evaluation and effect on the intestinal bacterial flora].
    Fujita K; Murono K; Saijyo M; Kakuya F; Yoshioka H; Maruyama S; Sakata H; Hiramoto A; Inyaku F
    Jpn J Antibiot; 1991 Nov; 44(11):1216-27. PubMed ID: 1784072
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical evaluation of ceftazidime in paediatrics].
    Haruta T; Ohkura K; Kuroki S; Kobayashi Y
    Jpn J Antibiot; 1984 Mar; 37(3):524-36. PubMed ID: 6376860
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Basic and clinical studies on norfloxacin in the pediatric field].
    Iwai N; Nakamura H; Miyazu M; Katayama M; Kasai K
    Jpn J Antibiot; 1990 Sep; 43(9):1629-48. PubMed ID: 2262968
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Fundamental and clinical studies on cefixime in pediatrics].
    Iwai N; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1986 Apr; 39(4):1087-105. PubMed ID: 3761539
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
    Nahata MC
    Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.
    Nau R; Sörgel F; Prange HW
    Clin Pharmacokinet; 1998 Sep; 35(3):223-46. PubMed ID: 9784935
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Nakazawa S; Sato H; Niinou K; Sunakawa K; Yokota T
    Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Laboratory and clinical studies of ceftazidime in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1984 Mar; 37(3):512-23. PubMed ID: 6376859
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Pharmacologic clinical monitoring of serum vancomycin levels in pediatric patients].
    Nandí-Lozano E; Ramírez-López E; Avila-Figueroa C
    Rev Invest Clin; 2003; 55(3):276-80. PubMed ID: 14515672
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chloramphenicol: new perspectives on an old drug.
    Powell DA; Nahata MC
    Drug Intell Clin Pharm; 1982 Apr; 16(4):295-300. PubMed ID: 7040026
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The monitoring of serum chloramphenicol levels in children with severe infections.
    Mulhall A; de Louvois J
    J Antimicrob Chemother; 1985 Dec; 16(6):809-10. PubMed ID: 4093349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.